Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments
Messenger RNA is a class of promising nucleic acid therapeutics to treat a variety of diseases, including genetic diseases. The development of a stable and efficacious mRNA pulmonary delivery system would enable high therapeutic concentrations locally in the lungs to improve efficacy and limit poten...
Main Authors: | Hairui Zhang, Jasmim Leal, Melissa R. Soto, Hugh D. C. Smyth, Debadyuti Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/11/1042 |
Similar Items
-
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
by: Abishek Wadhwa, et al.
Published: (2020-01-01) -
Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
by: Tongren Yang, et al.
Published: (2020-12-01) -
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
by: Ibrahim M. Abdulbaqi, et al.
Published: (2021-07-01) -
Long-term storage of lipid-like nanoparticles for mRNA delivery
by: Pengxuan Zhao, et al.
Published: (2020-06-01) -
PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)